Sodium phenylacetate and sodium benzoate
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Sodium Phenylacetate and Sodium Benzoate is an intravenous injection solution containing 100 mg/mL of each active ingredient. Manufactured by MAIA Pharmaceuticals, Inc., it's a prescription drug used to help remove excess ammonia from the blood in patients with certain metabolic disorders. Administered via IV infusion, it works by binding nitrogen compounds for excretion. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Sodium phenylacetate and sodium benzoate
Access the FDA dataset for Sodium phenylacetate and sodium benzoate β ANDA 205880 submitted by Mylan Institutional LLC
Modified Mar 24, 2026